SE7612963L - Tienamycinderivat - Google Patents

Tienamycinderivat

Info

Publication number
SE7612963L
SE7612963L SE7612963A SE7612963A SE7612963L SE 7612963 L SE7612963 L SE 7612963L SE 7612963 A SE7612963 A SE 7612963A SE 7612963 A SE7612963 A SE 7612963A SE 7612963 L SE7612963 L SE 7612963L
Authority
SE
Sweden
Prior art keywords
pharmaceutically acceptable
acceptable salts
gram
novel
tienamycin
Prior art date
Application number
SE7612963A
Other languages
English (en)
Other versions
SE427841B (sv
Inventor
B G Christensen
W J Leanza
K J Wildonger
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of SE7612963L publication Critical patent/SE7612963L/sv
Publication of SE427841B publication Critical patent/SE427841B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SE7612963A 1975-11-21 1976-11-19 Analogiforfarande for framstellning av tienamycinderivat SE427841B (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63429675A 1975-11-21 1975-11-21
US67626176A 1976-04-12 1976-04-12
US73365476A 1976-10-18 1976-10-18

Publications (2)

Publication Number Publication Date
SE7612963L true SE7612963L (sv) 1977-05-22
SE427841B SE427841B (sv) 1983-05-09

Family

ID=27417545

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7612963A SE427841B (sv) 1975-11-21 1976-11-19 Analogiforfarande for framstellning av tienamycinderivat

Country Status (27)

Country Link
AT (1) AT358168B (sv)
AU (1) AU512383B2 (sv)
BG (1) BG34037A3 (sv)
CA (1) CA1083577A (sv)
CH (2) CH632510A5 (sv)
DD (1) DD127742A5 (sv)
DE (1) DE2652679A1 (sv)
DK (1) DK157401C (sv)
EG (1) EG12261A (sv)
ES (1) ES453501A1 (sv)
FI (1) FI62306C (sv)
FR (1) FR2332012A1 (sv)
GB (1) GB1570990A (sv)
GR (1) GR62072B (sv)
HK (1) HK29683A (sv)
HU (1) HU180865B (sv)
IE (1) IE44433B1 (sv)
IL (1) IL50911A (sv)
KE (1) KE3286A (sv)
NL (1) NL189297C (sv)
NO (1) NO153298C (sv)
NZ (1) NZ182630A (sv)
PH (1) PH16714A (sv)
PL (1) PL110937B1 (sv)
PT (1) PT65865B (sv)
SE (1) SE427841B (sv)
SG (1) SG10983G (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1593524A (en) * 1976-11-19 1981-07-15 Merck & Co Inc 1-carba-2-penem-3-carboxylic acids
SE436569B (sv) * 1977-05-05 1985-01-07 Merck & Co Inc Analogiforfarande for framstellning av tienamycinderivat
US4232030A (en) * 1977-09-15 1980-11-04 Merck & Co., Inc. Substituted N-methylene derivatives of thienamycin sulfoxide and sulfone
DK153486C (da) * 1978-07-03 1988-11-28 Merck & Co Inc Analogifremgangsmaade til fremstilling af krystallinsk n-formimidoyl-thienamycin-monohydrat
EP0044170A1 (en) * 1980-07-11 1982-01-20 Beecham Group Plc Beta-lactam antibiotics, their preparation and use
CA2089261A1 (en) * 1990-08-30 1992-03-01 John F.W. Keana Substituted amidines having high binding to the sigma receptor and the use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1004670A (en) * 1963-04-23 1965-09-15 Beecham Res Lab Penicillins
GB1348984A (en) * 1970-06-16 1974-03-27 Merck & Co Inc Antibiotics and processes for their production
US3950357A (en) * 1974-11-25 1976-04-13 Merck & Co., Inc. Antibiotics

Also Published As

Publication number Publication date
NO763958L (sv) 1977-05-24
DD127742A5 (de) 1977-10-12
NO153298C (no) 1986-02-19
PH16714A (en) 1984-01-25
PL193809A1 (pl) 1978-01-16
IE44433L (en) 1977-05-21
KE3286A (en) 1983-06-17
PT65865B (en) 1978-10-12
DK523576A (da) 1977-05-22
PT65865A (en) 1976-12-01
NL189297B (nl) 1992-10-01
DK157401B (da) 1990-01-02
NL7612939A (nl) 1977-05-24
FI62306B (fi) 1982-08-31
ATA863476A (de) 1980-01-15
DE2652679C2 (sv) 1990-03-01
AU512383B2 (en) 1980-10-09
NZ182630A (en) 1979-07-11
SE427841B (sv) 1983-05-09
PL110937B1 (en) 1980-08-30
FR2332012A1 (fr) 1977-06-17
GB1570990A (en) 1980-07-09
AT358168B (de) 1980-08-25
BG34037A3 (bg) 1983-06-15
FR2332012B1 (sv) 1978-11-17
HU180865B (en) 1983-04-29
AU1964776A (en) 1978-05-25
GR62072B (en) 1979-02-20
CA1083577A (en) 1980-08-12
DK157401C (da) 1990-05-21
DE2652679A1 (de) 1977-06-02
EG12261A (en) 1978-12-31
FI763308A7 (sv) 1977-05-22
FI62306C (fi) 1982-12-10
NL189297C (nl) 1993-03-01
NO153298B (no) 1985-11-11
SG10983G (en) 1983-12-16
IL50911A (en) 1981-01-30
IL50911A0 (en) 1977-01-31
ES453501A1 (es) 1978-03-01
CH632510A5 (en) 1982-10-15
HK29683A (en) 1983-08-26
CH633800A5 (en) 1982-12-31
IE44433B1 (en) 1981-12-02

Similar Documents

Publication Publication Date Title
ES468475A1 (es) Procedimiento para la preparacion de derivados de cefem
ES485188A1 (es) Procedimiento para preparar 1-piperazina-carboxamidas y car-botiamidas
NO951198L (no) Lipopeptidderivater, fremgangsmåte for fremstilling derav og anvendelse av derivatene
AU555444B2 (en) Cephalosporin derivatives
ES470436A1 (es) Un procedimiento para la preparacion de un acido carboxilicoalilico
SE7514271L (sv) Sett att framstella nya 1,3-disubstituerade propanol-(2)-derivat
AU2957577A (en) Treatment of bacterial infections with pseudomonic acid
SE7612962L (sv) Tienamycinderivat
IE44433L (en) Derivatives of thienamycin and its isomers
IL35875A (en) Pharmaceutical compositions for the treatment of microbial infections containing an n-(3-carboxy-propionyl)glutamic acid derivative
SE7811455L (sv) 2-imino-imidazolidin-derivat
ES8504203A1 (es) Un procedimiento para preparar derivados de penem.
SE7612295L (sv) Antibiotikum
ZA792571B (en) Cephem derivatives and process for their manufacture
SE7612961L (sv) Tienamycinderivat
ES430676A1 (es) Procedimiento para la preparacion de 1,2,4-tiadiazolo- (2,3-a) bencimidazoles-2-sustituidos.
ES431943A1 (es) Procedimiento para preparar derivados de cefalosporina.
SE7707366L (sv) Forfarande for framstellning av 7alfa-metoxi-cefalosporansyraderivat
SE7612960L (sv) Tienamycinderivat
GB1028563A (en) Antibacterial derivative of 7-aminocephalosporanic acid
ES469840A1 (es) Procedimiento para la obtencion de nuevos derivados de tria-zolotiadiacinas.
NO821083L (no) Fremgangsmaate for fremstilling av terapeutisk aktive morfantridin-derivater
GB1533413A (en) Penicillins
FI864537A0 (fi) Kefalosporinderivat och foerfarande foer deras framstaellning.
NO890287L (no) Fremstilling av beta-laktam-antibiotika.

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7612963-4

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7612963-4

Format of ref document f/p: F